The data also indicate that cumulative changes in the F protein may enable MeV to use other fusion-triggering host molecules than CADM1 and CADM2, facilitating its spread in the brain of SSPE patients. The gene discussed is CADM2; the disease is subacute sclerosing panencephalitis.